In the face of stagnant healthcare budgets and ever-growing demand for care, pharmaceutical companies are under severe pressure to demonstrate the value of their products. Value-based pricing has exciting potential to help improve patient outcomes – and at an affordable cost.
In order to survive digital transformation and successfully secure its competitive edge in the long term, the Swiss economy will have to win out over a range of disruptive forces. In its whitepaper “Shaping Switzerland’s digital future”, KPMG outlines 7 areas of innovation and opportunity for Switzerland.
The higher the risk, the greater the return is a basic premise believed to also apply to business. The true art behind managing a business lies in maximizing profit while minimizing risk. It seems that CEOs abroad appear to be doing better at this balancing act than Swiss CEOs according to their self-assessment as expressed in KPMG’s CEO Outlook.